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ABSTRACT
Objective: To evaluate behavioural components and
strategies associated with increased uptake and
effectiveness of screening for coronary heart disease
and diabetes with an implementation science focus.
Design: Realist review.
Data sources: PubMed, Web of Knowledge, Cochrane
Database of Systematic Reviews, Cochrane Controlled
Trials Register and reference chaining. Searches limited
to English language studies published since 1990.
Eligibility criteria: Eligible studies evaluated
interventions designed to increase the uptake of
cardiovascular disease (CVD) and diabetes screening
and examined behavioural and/or strategic designs.
Studies were excluded if they evaluated changes in risk
factors or cost-effectiveness only.
Results: In 12 eligible studies, several different
intervention designs and evidence-based strategies
were evaluated. Salient themes were effects of
feedback on behaviour change or benefits of health
dialogues over simple feedback. Studies provide mixed
evidence about the benefits of these intervention
constituents, which are suggested to be situation and
design specific, broadly supporting their use, but
highlighting concerns about the fidelity of intervention
delivery, raising implementation science issues. Three
studies examined the effects of informed choice or
loss versus gain frame invitations, finding no effect on
screening uptake but highlighting opportunistic
screening as being more successful for recruiting
higher CVD and diabetes risk patients than an
invitation letter, with no differences in outcomes once
recruited. Two studies examined differences between
attenders and non-attenders, finding higher risk factors
among non-attenders and higher diagnosed CVD and
diabetes among those who later dropped out of
longitudinal studies.
Conclusions: If the risk and prevalence of these
diseases are to be reduced, interventions must take
into account what we know about effective health
behaviour change mechanisms, monitor delivery by
trained professionals and examine the possibility of
tailoring programmes according to contexts such as
risk level to reach those most in need. Further research
is needed to determine the best strategies for lifelong
approaches to screening.
Strengths and limitations of this study
▪ The study’s strength is its focus on what contri-
butes to the success and the reach of screening
plus intervention studies, based on health psych-
ology evidence.
▪ Its evaluation of the degree and fidelity with which
evidenced health behaviour strategies are used has
important implications for practitioners managing
screening and intervention programmes.
▪ Evaluation of opportunistic screening confirms pre-
vious work showing that it reaches people with
higher cardiovascular disease risk factors than
those reached using standard invitations, but add-
itionally demonstrates that people screened oppor-
tunistically show very similar improvements in
assessed risk factors and behaviours to people
invited in other ways.
▪ This review raised two key challenges. First, many
studies do not analyse behavioural components of
the intervention design discretely, making it
impossible to discern which factors are at work in
producing the observed effects. Second, the het-
erogeneity of outcome measures precludes statis-
tical evaluations using meta-analysis.
▪ Publication or outcome bias may have affected our
results, though not all included studies found sig-
nificant reductions in assessed risk or differences
in outcomes between the intervention and control
groups.
▪ Several potentially relevant studies focusing on the
design of screening interventions were excluded
because they were not delivered in healthcare
settings.
▪ Well-known selective dropout (‘selective attrition’)
biases are confirmed in these studies, whereby
people with more lifestyle risk factors (smoking,
higher alcohol consumption, overweight) are more
likely to fail to return for follow-up appointments.
Careful methodological and statistical controls are
needed to reduce resultant effects on findings, but
few studies employ these.
▪ As a realist review, this document examines out-
comes which may be situation specific. The acknowl-
edgement that some findings may be situation
specific is important in the generalisation of results.
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INTRODUCTION
Previous reviews of multiple risk factor interventions for
primary prevention of coronary heart disease (CHD)
and diabetes often conclude that interventions have no
overall effect on mortality.1 Nevertheless, CHD deaths
have halved in the UK and other developed countries in
the last 30 years.2 Unal et al3 compared targeted inter-
ventions and general population screening. They esti-
mated the proportion of reduced deaths from CHD in
England and Wales between 1981 and 2000 that were
attributable to changes in risk factors in patients with
CHD or changes in cardiovascular risk factors in the
general population, and found both approaches beneﬁ-
cial. These authors calculated that reductions in risk
factors (such as smoking and high blood pressure) in
the general population account for 50–75% of the fall in
cardiac deaths, and that pharmacological and surgical
treatments for diagnosed CHD patients account for 25–
50%.3 However, that beneﬁt was greater when indivi-
duals without CHD were screened: results indicated an
additional 21 years of life for each death prevented in
those with no CHD diagnosis compared with 7.5 years
for those with CHD.
Public health campaigns to reduce these conditions
usually involve: government-sponsored programmes at
the population level or changes in policy (such as food
labelling legislation); targeted interventions for those
at heightened risk (eg, moderate-intensity, low-impact
exercise for those very overweight or with chronic condi-
tions); or general population screening and intervention
to reduce risk development in the healthy population
and identify high-risk people leading to speciﬁc referral
for detected or previously untreated symptoms
(eg, current National Health Service Health Check4
programme).
This review focuses on quantitative evaluations of
screening plus intervention programmes that target the
general population to reduce the incidence of CHD and
diabetes. These conditions were selected because they
are the focus of screening programmes in many countries
and the negative outcomes of these conditions can be
ameliorated by lifestyle behaviour change. Previous
reviews have focused on reductions in risk measurements,
cost-effectiveness or years of life added.1 In contrast, the
primary objective of this review was to examine the use of
behaviour change features embedded within intervention
designs of screening programmes targeting CHD and dia-
betes and their impact on health outcomes. A secondary
objective was to evaluate the factors predicting attend-
ance and attrition from these programmes.
These objectives are not well suited to systematic
review and meta-analysis approaches, where the aim is to
synthesise results across contexts to gain a sense of the
pattern of results for studies conducted using similar
methodologies. In contrast, the present paper was
focused on questions around ‘how’ and ‘why’ behav-
ioural features are incorporated into interventions, and
how these features can contribute to the success of
interventions. Therefore, we adopted a realist review,
also called a meta-narrative approach. This approach
was adopted to gain insights into the direction in which
the evidence is pointing and the underlying theoretically
driven concepts, behaviour change mechanisms and bar-
riers, which may combine to contribute to outcomes in
population screening for CHD and diabetes.5 Focus on
the mechanisms and use of evidence-based behaviour
change strategies locate the review within an implemen-
tation science approach, given that ‘one of the most con-
sistent ﬁndings from clinical and health services
research is the failure to translate research into practice
and policy’ (Ref. 6, p.1).
A realist methodology7 is suited to areas where there is a
diverse literature, which may have a variety of methods,
components and outcomes. This methodology is con-
cerned with explaining more fully the processes of inter-
ventions within the complexity of their contexts, rather
than focusing on simple cause and effect deterministic the-
ories. Realist reviews can ‘contribute to programme under-
standings even when the outcomes are not rigidly deﬁned
at the outset of the review and have been characterised as a
theory-driven and interpretive approach to systematic
reviews to answer questions about what works, for whom
and in what circumstances’ (Ref. 8, p.4).
Inclusion of studies in a realist review is intended to
be less proscribed than in a systematic review to allow
for a mix of methods and outcomes to be included,
ensuring that underlying theories and approaches can
be evaluated rather than a focus on speciﬁc measured
outcomes. Inclusion criteria in this review of screening
plus intervention studies were generated using guidance
from systematic reviews on screening (PRISMA),9 but
were further generated iteratively using the themes that
emerged. The ﬂow chart and checklist are available as
supplementary material.
Data sources
Web of Knowledge, PubMed, Cochrane Database of
Systematic Reviews and Cochrane Controlled Trials
Register restricted to the English language and pub-
lished post-1990. Reference chaining of identiﬁed
studies was then conducted.
Search strategy
Search terms were adapted from previous Cochrane
reviews of screening plus uptake studies.10 11 The full
strategy is available in appendix 1. The search was ﬁrst
carried out in July 2010 and updated in March 2013.
Study selection
The initial inclusion criteria were: studies that tested
interventions designed to increase uptake of CHD and
diabetes screening programmes or to increase early
detection and prevention of these conditions and exam-
ined the behavioural and/or strategic design of the
intervention tested. Studies which only reported on
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changes in risk factors or cost-effectiveness were
excluded.
The initial search elicited 2323 relevant published
papers. The retrieved papers were screened according
to the inclusion criteria. Details of the screening and
exclusion stages are detailed in ﬁgure 1.
Following the screening of titles, 565 relevant papers
remained. The reference lists and citations of these
papers were searched (using PubMed and Web of
Knowledge) speciﬁcally to identify studies that evaluated
the behavioural aspects of the interventions tested; a
pragmatic approach was taken to ensure that articles
which may not have been found using such traditional
chaining were not missed, in that new keywords elicited
from themes of identiﬁed articles were added to the
search, notably on speciﬁc behavioural approaches. An
example was ‘informed choice invitation’. This process
identiﬁed a further 16 articles. Following the removal of
duplicates across sources (120), and removal after
abstract screening (304), two authors (CH and YC) inde-
pendently reviewed 157 full-text papers and further
excluded studies which only evaluated changes in risk
factors or cost-effectiveness. Further exclusions at the
abstract and full-text stages were guided by framing of
the interventions into their constituent components
using the Population, Intervention, Comparison,
Outcome and Type of study design (PICO(T) categories.
The review was concerned with general population
(adult) screening, and so interventions that considered
only those already identiﬁed as being at high risk of car-
diovascular disease (CVD)/diabetes or already receiving
treatment, younger or a speciﬁc age or disease-limited
Figure 1 Flow chart of intervention studies included and excluded from this review.
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groups were excluded. Although the initial reading
included interventions in a variety of settings, the selec-
tion of the ﬁnal set of papers restricted inclusion to
studies set in primary healthcare, in line with the aim of
this review being to inform primary healthcare-based
interventions. Comparison with a control group of some
nature was necessary for inclusion, and although most of
the identiﬁed studies did consist of randomised or
cluster randomised control trials, other designs were not
excluded, and the relevant quality appraisal criteria for
the different designs were used as appropriate (table 1).
Although most of the studies examined outcomes in
terms of a successful or unsuccessful lowering of CVD or
diabetic risk, the intention of this review was to deter-
mine ‘how, why and what works’ or what may prevent it
from working,7 so the outcome type was not restricted.
A preliminary examination of studies sought to extract
dominant themes reﬂecting the behavioural features of
‘how and why’ such interventions succeed or fail in
reducing CVD or diabetic risk. Most studies examined
the effect of a multicomponent intervention, in which
key features were engaging populations in screening,
providing screened populations with feedback about risk
status, a health dialogue (deﬁned as counselling that
includes aspects of shared decision-making such as goal
setting or intention formation, and is not just informa-
tion giving or psychological support), information about
the impact of risk factors on illness development, coun-
selling, motivational interviewing (MI), referral and
pharmacological treatment. The impact of feedback and
health dialogue on health outcomes was reported, but
due to the multiple constituents of interventions, isolat-
ing the effects of any one feature is often difﬁcult.
Search for studies that focused on explicitly examining
such features therefore developed. Twelve studies were
left that fulﬁlled this requirement and met the inclusion
criteria. Details of the components covered by these
papers, year of publication, samples recruited, popula-
tions studied and main ﬁndings are presented in table 1.
The selection process is summarised in a PRISMA ﬂow
diagram.
Data extraction
Two reviewers (CH and YC) independently extracted
information from each article, and one author (CH)
reviewed all the studies. Data were extracted on the
study authors, geographical location, year of publication,
study cohort characteristics, behavioural design features
of the intervention and outcome measures (see table 1).
RESULTS
Study characteristics and quality
The SIGN 50 assessment of quality of studies included is
summarised in table 1. Two authors (CH and RC) inde-
pendently rated each included study for quality using
the SIGN 50 guidelines,12 with each study rated as
++=high quality, +=acceptable quality or 0=low quality.
After independent ratings, the authors met to discuss
their ratings. All disagreements were resolved through
discussion. Seven studies were of acceptable quality and
ﬁve were high-quality studies. The key elements of the
studies are summarised in table 1, so that key themes
and evidence from the papers could be identiﬁed and
extracted for examination.
The review of included papers begins by describing
studies that addressed the question of what impact
behaviour change features embedded within interven-
tion designs of CVD and diabetes screening programmes
have on health outcomes. The review then proceeds to
cover literature that evaluates the factors predicting
attendance and attrition from screening and interven-
tion programmes.
Impact of feedback on behaviour change
Providing people with feedback on their behaviour can
prompt behaviour change,13 14 and has been recognised
as an effective behaviour change technique in Abraham
and Michie’s behaviour change taxonomy.15 16 In
general, there are two types of feedback: informing
patients about their risk status, for example, of CVD;
and giving patients behaviour-speciﬁc feedback, for
example, discussion related to detailed dietary analysis17
with a key point of contention being the effectiveness
and practicalities of these two approaches. Two studies
examined the impact of feedback on behaviour change.
Aubin et al18 investigated whether knowledge of blood
cholesterol level affected intention to adopt a low fat
diet. The study was conducted in hospital-based family
medical centres in Quebec, Canada. Participants were
randomly assigned to complete a questionnaire about
CVD risk proﬁle, intention to adopt a low fat diet and
dietary fat intake either before or after receiving their
screening results, that is, one group knew their results,
and one did not at the time of completing the question-
naire. Patients who were aware of their blood screening
results before they completed the questionnaire showed
a signiﬁcantly higher intention to adopt a lower fat diet
than patients who were not (F1,417=5.4, p<0.02). In add-
ition, in those who had received their results, intention
tended to rise with the blood cholesterol level (non-
signiﬁcant, F5,413=2.0, p<0.08).
Three months after screening, participants’ dietary fat
intake and changes in eating habits were assessed by
comparing their diet with that reported at baseline. Data
for 391 participants (mean age=35 years) were analysed.
The mean dietary fat intake reduced signiﬁcantly from
48.5 g/day at baseline to 37.7 g/day at 3-month
follow-up for the participant group as a whole. After
3 months, patients who had abnormal cholesterol levels
had a signiﬁcantly greater reduction in dietary fat intake
than patients with normal cholesterol results (F(2,388)
=3.6, p=0.03); correlational analysis showed a highly sig-
niﬁcant link between reduction in fat intake and reduc-
tion in blood cholesterol (the researchers report an R2
of 0.5, p=0.001, but conﬁrmed by email that a Pearson’s
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Table 1 Included studies
Study Country Sample N Design
Intervention
component Main findings Quality
Aubin et al18 Canada 58% female, mean age
35 years
391 RCT, controls completed
questionnaire on intention to eat a low
fat diet before they received results of
cholesterol screening, intervention
participants completed it after.
Impact of feedback
on behaviour
change
Intervention participants were more
likely to intend to adopt a low fat diet
than controls. Patients with abnormally
high cholesterol(>6.3 mmol/L) showed
a greater reduction in dietary fat intake
than those who had a normal
cholesterol (<5.2 mmol/L).
+
Elton et al19 England 44% female, mean age
37.9 years
469 Prospective, blinded RCT, intervention
participants knew their cholesterol
level before the health education and
diet session, control participants did
not.
Impact of feedback
on behaviour
change
Participants whose initial serum
cholesterol was ≥6.5 mmol/L, and who
had been informed of this, showed a
significantly greater reduction in serum
cholesterol than control participants in
the same high cholesterol group who
had not been informed. All participants
received the same dietary advice.
++
Färnkvist et al20 Sweden 100% male, age
stratified, aged 66, 56
and 46 years
817 Cross-sectional study. Screening only,
screening plus health dialogue by
trained professionals and
non-participants compared.
Benefits of health
dialogue over
simple feedback
ORs of developing diabetes or CVD
over 11 years were 2.5 for those who
had received screening with no health
dialogue and 3.0 for those who had not
participated in the original screening,
as compared with those who had
received screening plus a structured,
motivational health dialogue.
+
Engberg et al21 Denmark 52% female, mean age
40.4 years
1507 RCT, screening, screening plus health
dialogue compared with a normal care
control group.
Benefits of health
dialogue over
simple feedback
After 5 years, there were no differences
between the two intervention groups.
Total intervention/control Risk Ratio
was 0.54. Absolute risk reduction was
8.6%.
++
Rubak et al22 Denmark 42% female, mean age
61 years. Patients with
screen-detected type 2
diabetes
628 Cluster RCT, intervention and control
groups received training in intensive
treatment of diabetes, intervention
group GPs additionally received
training in motivational interviewing
(MI) and were instructed to use it.
Benefits of health
dialogue over
simple feedback
No effect of motivational interview on
medication adherence or metabolic
status relative to the control group.
Medication adherence across both
groups was almost 100%, both groups
showed significant improvements in all
risk measures. Key issues were lower
than the planned use of motivational
interview by intervention group GPs,
and contamination of methods and
training into control group GPs
++
Koelewijn-van
Loon et al23
Netherlands 55% female, mean age
57 years
615 Cluster RCT, intervention nurses
received training to use risk.
Outcome measures were self-reported
lifestyle measures. No differences
+
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Table 1 Continued
Study Country Sample N Design
Intervention
component Main findings Quality
assessment, communication, a
decision support tool and MI. Control
group nurses received training on risk
assessment and applied usual care.
Benefits of health
dialogue over
simple feedback
between control and intervention
groups were noted at 12-week
follow-up, but overall both groups
showed improvements.
Craigie et al24 Scotland 72% female, mean age
54.5 years, high risk but
not on statins
75 RCT, intervention—motivational
interview and volitional aspects to
change planned behaviour, control
group usual care.
Benefits of health
dialogue over
simple feedback
Percentage achieving 5 portions of fruit
and vegetables a day and weight
maintenance or loss indicators was
significantly better in the intervention
group over the 12-week follow-up.
Control group made no positive
change.
+
Marteau et al26 England 47.6% female, mean age
57.4 years
1272 RCT, informed choice invitation
compared with standard invitation.
Impact of type of
invitation on
uptake and
outcome
Primary outcome of attendance did not
differ between groups. Secondary
outcome of intention to change health
behaviour was unaffected by invitation
type.
++
Park et al27 England 66.6% male, mean age
58 years
116 RCT, loss frame compared with gain
frame invitation.
Impact of type of
invitation on
uptake and
outcome
Primary outcome of attendance did not
differ between groups (invitation types).
Secondary outcome measures of
anxiety, self-perceived health and
illness representation also did not differ
between groups.
++
Hellénius et al28 Sweden 65% female, age range
20–60 years
4904 Observational cross-sectional study,
those screened as a result of
opportunistic invitations compared
with those responding to a letter
invitation.
Impact of type of
invitation on
uptake and
outcome
Opportunistically screened participants
showed higher CVD risk factors than
letter invited participants at baseline.
Effectiveness of screening in lowering
risk factors did not differ between the
two groups.
+
Jones et al29 Wales 53.4% female, mean age
42.5 years
2542 Observational cross-sectional study,
those not responding to initial
invitations to screenings compared
with those who did.
Differences
between attenders
and non-attenders
Non-attenders showed more risk
factors than attenders.
+
Thomas et al30 England 100% male, mean age
69.1 years
5655 Observational cross-sectional study,
health characteristics of those who
attended and those who did not
attend a 20-year follow-up were
compared.
Differences
between attenders
and non-attenders
Despite no differences at baseline in
BMI and cholesterol, those who later
dropped out of a longitudinal study had
higher blood pressure at baseline and a
greater number of CVD and bronchial
diagnoses, and adverse lifestyle factors
(eg, OR of smoking in non-attenders
2.33).
+
Note: SIGN 50 cohort checklist used to assess study quality.
++=high quality study, +=acceptable, 0=unacceptable; BMI, body mass index; CVD, cardiovascular disease; GP, general practitioner; RCT, randomised controlled trial.
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correlation was intended). This shows that patients who
had higher blood cholesterol were more likely to make
dietary changes. Although the method and analysis did
not separate out people who were aware of their choles-
terol levels in the longitudinal comparisons, the authors
concluded that informing patients of their blood choles-
terol levels effects an immediate change in dietary
habits, and that over all, the change in dietary habits
effects a reduction in fat intake and lower CVD risk.
Elton et al19 used a workplace screening and interven-
tion trial in Manchester, UK to examine if knowledge of
cholesterol level led to a reduction in cholesterol over a
13-week period. Participants were randomly allocated to
either an intervention group, which received informa-
tion on their current cholesterol level, or to a control
group where this information was not provided. Then all
participants attended a health education session about
diet. The results demonstrated that the reduction in
cholesterol measurements 13 weeks after baseline was
greater in intervention participants with initially high
(>6.5 mmol/L) serum cholesterol than in matched
control participants (change of –0.29 for intervention
participants, 95% CI −0.48 to −0.11, but only a change
of −0.01, 95% CI −0.16 to 0.15 for controls, difference
between groups reached signiﬁcance at p<0.024). A key
difference between this and an earlier study,18 which
had not shown an effect of informing participants of
their cholesterol level, was that the interventions speciﬁc-
ally focused on diet here, whereas the earlier study deliv-
ered a general health education package.
Impact of health dialogue on behaviour change
Five studies examined the role of health dialogue in
inﬂuencing health outcomes of screening interven-
tions.20–24 Färnkvist et al20 investigated the extent to
which health screening with or without health dialogue
inﬂuenced self-reported CVD and diabetes morbidity
11 years postscreening. Participants were men aged 35–
55 years in Härnösand, Sweden. Screening included
objective measurements (eg, blood pressure), a self-
report questionnaire and health counselling provided by
nurses. Although described alternately as health dia-
logue and counselling in this study, it did actually consist
of a structured motivational dialogue that included dis-
cussion of the individual’s CVD risk, as well as of the
possible lifestyle changes, and hence fulﬁls our deﬁn-
ition of a health dialogue. Other healthcare providers in
the same community (mainly occupational health ser-
vices) carried out the same screening but without the
health dialogue.
Eleven years later, participants were asked to complete
a questionnaire including questions about smoking,
alcohol, physical activity, height, weight, fat intake and
the presence of CVD and/or diabetes. There was no sig-
niﬁcant decline in health during the 11 years for those
participants who received the screening plus health dia-
logue (8.2% incidence of CVD and/or diabetes), in
stark contrast to those who received screening only
(22.6% incidence) or no screening (19.2%). The OR of
developing CVD or diabetes over the 11 years was 2.5 for
those who had screening with no health dialogue, and
3.0 for those who had not participated in either the ori-
ginal screening or the dialogue, as compared with the
dialogue group. That is, the risk was more than doubled
for any group that had not received the dialogue. The
authors concluded that screening that includes a struc-
tured, motivational health dialogue is more effective
than screening without this dialogue.
Engberg et al21 conducted a randomised controlled
trial in Denmark investigating the impact of general
health screening versus screening plus general practi-
tioner (GP)–patient discussions about CVD risk proﬁle.
Randomly selected men aged 30–50 years from several
GP practices were sent an invitation letter and postal
questionnaire about lifestyle. Those who agreed to take
part completed a second questionnaire asking about
their health, lifestyle, psychosocial status and life events.
Participants were randomised to a control group (ques-
tionnaire only, no screening) or one of two intervention
groups: screening only and screening plus health discus-
sions (time points not given). Participants in the health
screening plus discussion group were offered a 45 min
consultation with their GP to discuss their results and
how to adapt to a healthier lifestyle. They were encour-
aged to set their own topics for discussion and to set
health-related lifestyle goals to achieve within the next
year. These participants were offered further discussions
annually for 5 years. Randomisation to groups was strati-
ﬁed based on the GP with whom they were registered,
age, sex, body mass index (BMI) and ‘cohabitation
status’. All screened participants received personal
written feedback from their GPs, including advice on
lifestyle change (where necessary) and information leaf-
lets about a healthy lifestyle. All participants were fol-
lowed up at 1 and 5 years.
At the 5-year follow-up, there were no signiﬁcant dif-
ferences in measures of CVD risk factors between the
two intervention groups (screening only vs screening
plus discussion). Taken together, however, these two
intervention groups had a much lower proportion of
patients with elevated CVD risk scores than the control
group, whose prevalence of elevated CVD risk was
approximately twice that of the intervention groups
(RR=0.54, 95% CI=0.40 to 0.73). However, there were no
signiﬁcant differences between the control and interven-
tion groups for blood pressure, and no effects on
smoking. The authors concluded that though the inter-
vention as a whole had a marked effect on CVD risk, the
discussions did not improve the cardiovascular health of
participants over and above the improvement shown
from screening with feedback.
Rubak et al22 examined the difference in patient out-
comes (improved metabolic status in patients with dia-
betes) between those whose GPs had received training
in MI and those whose GPs had been allocated to a
control group. Both groups of GPs received training in
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intensive treatment of type 2 diabetes. The study found
that patients with GPs in both groups showed signiﬁcant
improvements, with no difference between the groups at
1-year follow-up. One explanation for the lack of differ-
ence found is that GPs in the motivational interview
group had used an average of less than two of the three
motivational interview sessions allocated to them. The
authors suggest that some contamination of effect may
have occurred, in that the control group GPs also
became aware of MI, and that the GPs in the motiv-
ational interview group did not use it as much as had
been recommended.
Koelewijn-van Loon et al23 investigated differences
between participants who had a structured dialogue with
a trained nurse (including risk assessment, risk commu-
nication, motivational interview and a patient ‘decision
support tool’) and patients who received usual care.
Outcome measures were self-reported lifestyle beha-
viours, diet, exercise, smoking and alcohol use, which
were measured 12 weeks after baseline to assess change.
Five hundred and twenty-two patients completed the
follow-up measures. The authors concluded that the
results showed an improvement in lifestyle in both
groups; there were no differences between groups in
terms of effects.
Craigie et al24 examined the impact of a personalised
lifestyle programme (HealthForce) aimed at promoting
lifestyle behaviour change and based speciﬁcally on
health behaviour change theory. HealthForce targeted
motivational elements to create intentions to change
behaviour and volitional elements, focusing on translat-
ing intentions into planned behaviours. It involved
patients attending three face-to-face sessions with a
trained lifestyle counsellor, plus other materials, with
topics being activity, diet and weight management. The
outcome assessments all showed signiﬁcant positive
changes for the intervention group (all p<0.01), with no
positive but some negative changes for the control
group. Consumption of ﬁve portions of fruit and vegeta-
bles a day went from 56% to 85% for the intervention
group; weight was down by an average of 1.1 kg, BMI
went from a mean of 26.7–26.2 kg/m2 (with increases,
rather than decreases, for the control group, p<0.01)
and waist circumference went from 87.3 to 84 cm (no
signiﬁcant change for the control group).
The contrast between these ﬁve similar studies is strik-
ing; Färnkvist et al and Craigie et al’s analyses supported
the impact of health dialogue, Engberg et al found that
screening plus verbal health dialogue was not superior
to screening that included a written dialogue, while
Rubak et al and Koelewijn-van Loon et al found no
effect. However, the outcome measures, and time
between measurements, vary across studies; Färnkvist
et al compared risk of CVD and diabetes diagnosis over
11 years, Engberg et al assessed differences between
groups in risk factors 5 years after initial screening,
Rubak et al tested metabolic status in patients with dia-
betes after 1 year, Koelewijn-van Loon et al compared
self-reports of lifestyle behaviours 12 weeks after the
intervention, and Craigie et al compared anthropometric
and health behaviour changes 12 weeks later. This raises
a number of issues. First, endpoint diagnosis is the most
objective measure of the impact of intervention, as well
as providing the strongest evidence of efﬁcacy. Second,
in general, longer term follow-ups are preferable;
however, selective attrition could be a greater issue for
longer term follow-ups, biasing the sample. Conversely,
shorter term follow-ups may not allow enough time for
change to happen. Finally, these studies, though con-
ducted with similar samples, were run in four different
countries with subsequent differences in healthcare ser-
vices and risk levels at baseline, and so conclusions need
to take into account the healthcare context when asses-
sing the mechanisms and outcomes.7
Of particular interest were the two studies which both
used self-reported behavioural outcomes and a 12-week
follow-up and yet had contradictory results (Craigie et al
and Koelewijn-van Loon et al). Both included
face-to-face counselling on more than one occasion, tele-
phone support sessions and motivational interview plus
decision support or goal setting. The most obvious dif-
ference is that patients in Craigie et al’s study were all
preselected as high risk (but not on statins), whereas
only 28% of those in Koelewijn-van Loon et al’s study
were designated as high CVD risk. Indeed, the latter
study did ﬁnd a difference between the intervention and
control groups in fruit and vegetable consumption when
only those with diagnosed diabetes were included. As in
previous analyses, the difference seems to be due to the
ﬁnding that those with a higher perceived risk are more
likely to make appropriate changes to their health
behaviour. Again, context is highlighted, but here in
terms of the individuals one is trying to inﬂuence.
Key points
▪ Providing patients with feedback on screened measurements
can promote changes in behavioural intentions and actual
health behaviour change.
▪ The benefits of a structured, motivational health dialogue are
supported over simple screening where outcomes are mea-
sured in the long term, but the actual structure of such dialo-
gues has not been directly analysed in the literature.
▪ The comparison of similar studies highlights the need for a set
of basic standardised measures.
▪ Comparisons suggest that longer term influences on disease
occurrence need assessing.
▪ Patients informed that they are at high risk tend to make the
most lifestyle changes and achieve the most positive outcomes.
Factors predicting the uptake, attendance and attrition from
screening programmes: uptake and invitation
For screening programmes to be cost-effective, it is
essential to maintain high levels of uptake and attend-
ance and avoid excessive attrition. Research25 has
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demonstrated that some groups, for example, the less
healthy, are less likely to participate in screening pro-
grammes and more likely to drop out if they do start
participating. Attempts have been made to encourage
the uptake of screening by manipulating the method of
invitation: three studies examined the effect of invitation
style on uptake and health outcome.26–28
Marteau et al26 hypothesised that providing an
informed choice leaﬂet would lower attendance relative
to standard invitations, because individuals receiving the
leaﬂet would see that screening is unlikely to provide
individual beneﬁts. The authors found no difference in
attendance rates between individuals who received an
informed choice letter versus a standard letter, but they
did replicate previous studies in ﬁnding that attendance
fell with increasing social deprivation. There was no
interaction between social deprivation and invitation
type; however, the authors concluded that the ethical
advantage gained in informed choice invitations did not
outweigh the attendance beneﬁt of standard invitations.
Park et al27 investigated the effects of loss-framed and
gain-framed messages in an invitation to screen for type 2
diabetes. The loss frame message (‘If you have diabetes
but are not detected early, your diabetes may lead to
more complications’) highlights the possible losses due
to not attending; the gain frame message (‘If your dia-
betes is detected early, you can receive early and more
effective treatment’) emphasises the possible gains of
attending. Participants aged 40–69 years were randomly
selected from two GP practices in Cambridgeshire,
England. Fifty-nine patients were randomised to receive
the loss-framed invitation and 57 the gain-frame invita-
tion. All invitations included a neutral framed message
(‘A simple blood test is the best way to detect diabetes’).
There were no signiﬁcant differences in attendance
rates between groups (loss-frame=81% vs gain-
frame=82%). Overall, results show that how information
was framed made little difference to the attendance rates.
There was, however, a signiﬁcant interaction effect
between sex and invitation frame; attendance was higher
in men invited using the loss-frame (89%) compared with
the gain-frame (77%), and higher in women invited using
the gain-frame (94%) compared with the loss-frame
(68%). Although this result should be viewed with caution
because of the small numbers, it does suggest a potential
for using different frames for different patient groups.
In addition to investigating the content and format of
invitation letters, researchers have also examined the
potential of opportunistic screening, that is, asking
patients to complete screening while they are attending
a healthcare setting for another purpose, such as collect-
ing medication. Hellénius et al28 investigated opportunis-
tic screening on visits to a healthcare centre for other
purposes in a suburban area of Sweden (Sollentuna).
Male and female adults under the age of 60 who visited
health centres were opportunistically invited to the
screening. This group was compared with a group which
was invited by letter. Fifty-nine per cent of those invited
by letter participated (249 people) compared with 15%
of the men and 20% of the women who were invited
when they visited their health centres (4655 people, the
opportunistic sample). The frequencies of hypertension,
high cholesterol and high triglycerides were greater in
the opportunistic sample than in the letter-invited
sample, but there were no differences in smoking or the
likelihood of being overweight. The outcomes of the
intervention showed signiﬁcant blood pressure, choles-
terol and triglyceride reductions, but no differences in
the level of reductions in risk factors between opportun-
istic and letter-invited participants. The authors con-
cluded that the integration of a large scale CVD risk
screening programme into a regular primary healthcare
system was successful and that, taking into account the
low uptake, opportunistically screening patients was suc-
cessful in identifying those with high CVD risk factors
whose risk factor level could be reduced.
Difference between attenders and non-attenders
It has been noted that differences exist between indivi-
duals who attend screening and those who do not,25 and
our search strategy identiﬁed two papers on this topic.
Jones et al29 recruited 3800 patients (aged 25–55 years)
across six GP practices in Wales who were invited for a
CHD risk factor screening programme. Two thousand four
hundred and two (63.2%) attended for screening,
whereas 1389 (36.8%) did not attend. A 1 in 10 random
sample of 140 non-attenders was obtained using a further
letter offering them a medical ‘MOT’ with speciﬁc refer-
ence made to heart disease and asking them to make an
appointment any morning or afternoon. (MOT is an
annual car maintenance test which is legally required by
the Department of Transport for cars on UK public roads,
a term which is very familiar in the UK.) After 3 weeks, any
persisting non-respondents were sent another letter
including a speciﬁc appointment time, asking them to
contact the surgery if this was not convenient. A ﬁnal
contact was made by telephone after a further 3 weeks,
and the nurse visited the home for the appointment if
necessary. This approach resulted in 98 (70%) of the ori-
ginal non-attenders being screened. They were asked to
indicate reasons for their initial non-attendance. Reasons
(in order of frequency) were: invitation letter not received
(36.7%); ‘practical reasons’ (26.5%); felt screening was
unnecessary because they were feeling well (18.4%);
already under medical care for CHD-related issues
(12.2%); already aware of having risk factors and so felt
screening was unnecessary (10.2%); felt apathetic about
screening (10.2%); afraid of screening (7.1%); forgot to
attend appointment (4.1%).
Non-attenders were signiﬁcantly older than attenders
(mean age 42.6 years and 39.4 years, respectively;
p<0.001, 95% CI of difference 1.50, 4.88). They were
more likely to have lower socioeconomic status (SES)
than attenders and more likely to have a personal
history of CHD (12% vs 5.7%, p<0.05). In addition,
mean BMI (p<0.01; 95% CI 0.84 to 2.58), cholesterol
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(p<0.01, 95% CI 0.26 to 0.74) and blood pressure (sys-
tolic p<0.001; 95% CI 9.57 to 15.86; diastolic p<0.01;
95% CI 1.63 to 5.82) were signiﬁcantly higher for non-
attenders than attenders. These results show that those
people most in need of healthcare are less likely to
access it. However, it is also clear that approximately
22% of non-attenders did not attend because they were
already under medical care for CHD issues or were
already aware of their risk factors (no data for atten-
ders), possibly inﬂuencing the outcome differences
between attenders and non-attenders, and potentially
reducing the likelihood of these individuals responding
to an invitation for screening.
A further issue of non-attendance is that of differences
between people who continue in a programme once
they have has started and those who drop out. Thomas
et al 30 examined the characteristics of attenders and
non-attenders at the 20-year follow-up screening in the
British Regional Heart Study. The non-attenders
referred to here were all people who had attended ori-
ginally, but failed to return for reassessment, that is, had
dropped out. A total of 7735 men took part in the ori-
ginal screening, and 4252 (77%) attended the follow-up.
There were no signiﬁcant differences at baseline in age,
BMI and cholesterol between those who attended those
and who did not attend at the follow-up, but non-
attenders at the follow-up had a higher baseline blood
pressure. Questionnaire data on the non-attenders was
available from 2 to 4 years before the invitation to the
follow-up health check. This showed that they were
more likely to have suffered stroke, peripheral vascular
disease and bronchitis and that they were twice as likely
to smoke cigarettes. Attenders were signiﬁcantly more
likely to be married, to own their own home, to have
access to a car and to be educated past the age of 16.
Mortality rates within 1 year of follow-up were signiﬁ-
cantly higher among non-attenders than attenders
(6.2% vs 1.7%), though the majority of deaths were non
CVD-related. Non-attenders who self-reported having
poor or fair health and a disability were signiﬁcantly less
likely to attend for follow-up, as were participants who
reported using four or more medications regularly.
Furthermore, non-attenders were shown to be taking
multiple prescribed medications, reporting more disab-
ling conditions and had a high early mortality rate.
DISCUSSION
This realist review focused on the use of evidence-based
design features of interventions which aimed to increase
uptake of CVD and diabetes screening with a view to
increasing early detection and reduction of risk factors for
these diseases. Only 12 studies were identiﬁed that critic-
ally examined the intervention design and tested the efﬁ-
cacy of health behaviour change components, such as
feedback, against health outcomes. Key ﬁndings include
the following: health-related feedback or health dialogue
can be effective, but in order to enable speciﬁc analyses, a
working deﬁnition of what this communication entails is
required; whether individuals are invited for screening or
are screened opportunistically may inﬂuence the nature of
participants recruited, with those at higher risk less likely
to respond to an invitation; and selective attrition of those
at higher risk may be skewing the results of longitudinal
studies because it is the healthier, lower risk patients who
are most likely to attend for follow-up.
Impact of behavioural features on the quality
and outcome of interventions
It is clear from the studies reviewed that consideration of
the evidenced behavioural features of interventions is
limited; in particular, several large UK studies25 31 32 were
excluded from the review at an early stage in the search
process because they did not examine any design, behav-
ioural or psychological features of screening or interven-
tion. Nevertheless, the studies included in the review
indicate several strategies that could be usefully employed
to reduce risk in high-risk and general population targets,
such as providing opportunistic screening. There was a lack
of evidence that intervention design was based on health
psychology theory (eg, Ajzen’s theory of planned behav-
iour),33 despite research showing that such theories can
predict screening attendance,34 and lifestyle behaviours
that are the target of screening interventions.35 Even
studies that claimed to be based on theories and target
Key points
Informed choice invitations are preferable ethically and do not
appear to reduce screening uptake. Framing of invitations to
screen may affect attendance rates for men and women; where a
screening invitation is gender specific, targeting may benefit from
framing.
▪ Opportunistic screening at visits to GP surgeries for other pur-
poses is shown to be effective
▪ Evaluation of opportunistic screening confirms that it reaches
people with higher CVD risk factors than those reached using
standard invitations.
▪ People screened opportunistically showed very similar improve-
ments in assessed risk factors to people invited in other ways
People who do not attend or who drop out at later stages may
be different.
▪ Differences between people who respond to invitations for
screening and those who do not are difficult to ascertain, but
evidence suggests that non-attenders have higher CVD risk
factors.
▪ Selective dropout (‘selective attrition’) biases longitudinal
studies in that inevitably people who are less healthy, less well
educated, of lower SES or with more lifestyle risk factors
(smoking, higher alcohol consumption, overweight) are more
likely to fail to return for follow-up appointments.
▪ Selective attrition may result in outcomes in longitudinal studies
appearing more positive (overestimate of effect) because the
people who remain in the study are healthier.
▪ Careful methodological and statistical controls are needed to
reduce resultant effects on findings.
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motivation24 failed to specify the theory base for their inter-
vention. This lack of emphasis on health psychology theor-
ies suggests a greater focus on the outcome of the
intervention (ie, did people change their behaviour?)
rather than a focus on the motivations and perspectives of
the individuals invited to screen. This ‘one-size ﬁts all’
approach to intervention design is unlikely to yield success
as research shows that even in a sample of 10 participants
not all of them respond positively to the same interven-
tions.36 Although there was limited use of health psych-
ology theories in the design of the interventions included
in this review, several interventions included elements such
as the inﬂuence of health dialogue, goal setting and feed-
back, which have been shown to promote health behaviour
change,37 38 although much of this research has been con-
ducted outside of primary care settings. Therefore, it was
encouraging to ﬁnd that goal setting promoted changes in
outcomes in Craigie et al and that feedback was helpful in
Aubin et al and Elton et al. These elements require further
examination with reference to a behaviour change tax-
onomy, for example, Abraham and Michie’s,15 to deter-
mine whether they are effective within the context of CVD
and diabetes screening programmes. Relatedly, an issue
highlighted by our evaluation of a CVD screening interven-
tion in the UK39 is the extent to which healthcare practi-
tioners use the strategies and tools with which they have
been provided in the health dialogues they have with their
patients. This issue of intervention ﬁdelity has the potential
to differentiate between programmes that are successful in
getting patients to change their behaviour and pro-
grammes that are not,40 and is evident in Rubak et al22 who
found that GPs failed to deliver, on average, more than one
session of motivational interview to patients, when they
were facilitated to deliver three. CERAG’s deﬁnition of
implementation research: ‘the scientiﬁc study of methods
to promote the systematic uptake of clinical research ﬁnd-
ings and other evidence-based practices in routine practice,
and hence to improve the quality (effectiveness, reliability,
safety, appropriateness, equity, efﬁciency) of healthcare’
(cited in Eccles et al41) sets this study ﬁrmly in the context
of implementation science.
Study limitations
This review raised two key challenges. First, studies rarely
analyse behavioural components of the intervention
design discretely, making it impossible to discern which
factors are at work in producing the observed effects.
Second, the heterogeneity of outcome measures precludes
statistical evaluations using meta-analysis. Publication or
outcome bias may have affected our results, though not all
included studies found signiﬁcant reductions in assessed
risk or differences in outcomes between the intervention
and control groups. Several potentially relevant studies
that focus on the design of screening interventions were
excluded because they were not delivered in healthcare
settings. The reviewed studies also highlight the disadvan-
tages of intention-to-treat analyses, which are better suited
for assessing the efﬁcacy of an intervention in practice, as
opposed to understanding ‘how’ and ‘why’ an interven-
tion works, and the need to control for selective attrition
either by the use of features which reduce dropout or by
statistical control for known differences between returners
and non-returners, but few studies employ this. As a realist
review, this document examines outcomes which may be
situation speciﬁc. The acknowledgement that some ﬁnd-
ings may be situation speciﬁc or population speciﬁc is
important in the generalisation of results.
Conclusions and policy implications
This review highlights the need for a more systematic
approach to the strategic design, conduct and analysis of
health interventions by taking into account the complex
interactions between the design, delivery, attrition and
health outcomes. It is recommended that insights from
health psychology should be incorporated in the design
of interventions aimed at increasing screening uptake,
as well as involving cross-disciplinary specialist areas such
as physical activity and nutrition to promote lifestyle
behaviour change alongside pharmacological treatment.
Furthermore, to control the effects of selective attrition,
there is a need to perform sensitivity analyses in order
to monitor the make-up of the sample and perhaps
some purposive sampling to protect against biasing the
sample towards a healthier baseline and therefore
reduced effect at follow-up, particularly in longitudinal
studies. It is anticipated that such carefully designed
interventions would result in health behaviour change
that provide as much beneﬁt to the wider population as
they do for those with heightened risk, resulting in
better overall population outcomes.
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APPENDIX
1. Search terms used in search strategy
The following terms were used in all data sources: (cardiovascular OR
vascular OR CVD OR ‘chronic heart disease’ OR ‘coronary heart
disease’ OR CHD OR diabetes) AND (‘mass screening’ OR surveil-
lance*) AND (letter OR mail* OR phone OR telephone OR ‘reminder
system*’ OR ‘videotape recording*’ OR ‘audiotape recording*’ OR
questionnaire* OR strateg* OR alert* OR hotline OR community OR
media) AND (intervention* OR goal OR ‘behav* change’ OR ‘imple-
mentation intention*’ OR plans OR planned OR planning OR plan OR
educat* OR campaign* OR barriers OR intention* OR ‘behav*
outcome’ OR outcome OR ‘lifestyle change’ OR longitudinal OR ‘follow
up’ OR motivation*) AND (satisf* OR dropout* OR ‘drop out’ OR attri-
tion OR uptak* OR adher* OR compliance OR complie* OR comply*
OR ‘patient acceptance of health care’ OR encourag* OR improve* OR
improving OR increas* OR promot* OR particip* OR nonattend* OR
‘non attend’ OR accept* OR attend* OR attitud* OR utilisation OR util-
ization OR refus* OR respond* OR respons* OR reluctan* OR nonre-
spon* OR ‘non respon*’ OR incidence OR prevalence OR prevelence
OR satisfaction OR cooperat* OR ‘co operat*’) AND (findings OR inter-
view* OR qualitative OR experienc* OR RCT OR ‘randomised con-
trolled trial’ OR trial).
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